Literature DB >> 24354800

Critical stoichiometric ratio of CD4(+)  CD25(+)  FoxP3(+) regulatory T cells and CD4(+)  CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia.

Kaushik Bhattacharya1, Sarmila Chandra, Chitra Mandal.   

Abstract

Regulatory T (Treg) cells act to suppress activation of the immune system and thereby maintain immunological homeostasis and tolerance to self-antigens. The frequency and suppressing activity of Treg cells in general are high in different malignancies. We wanted to identify the role and regulation of CD4(+)  CD25(+)  FoxP3(+) Treg cells in B-cell acute lymphoblastic leukaemia (B-ALL). We have included patients at diagnosis (n = 54), patients in clinical remission (n = 32) and normal healthy individuals (n = 35). These diagnosed patients demonstrated a lower number of CD4(+)  CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor-β and CD152/CTLA-4 than the normal population. Treg cells from patients showed a higher suppressive capability on CD4(+)  CD25(-) responder T (Tresp) cells than normal. The frequency and immunosuppressive potential of CD4(+)  CD25(+)  FoxP3(+) Treg cells became high with the progression of malignancy in B-ALL. Relative distribution of Tresp and Treg cells was only ~5 : 1 in B-ALL but ~35 : 1 in normal healthy individuals, further confirming the elevated immunosuppression in patients. A co-culture study at these definite ex vivo ratios, indicated that Treg cells from B-ALL patients exhibited higher immunosuppression than Treg cells from normal healthy individuals. After chemotherapy using the MCP841 protocol, the frequency of CD4(+)  CD25(+) cells was gradually enhanced with the reduction of FoxP3, interleukin-10 positivity corresponded with disease presentation, indicating reduced immunosuppression. Taken together, our study indicated that the CD4(+)  CD25(+)  FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients. To the best of our knowledge, this is the first detailed report on the frequency, regulation and functionality of Treg cells in B-ALL.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  B-cell acute lymphoblastic leukaemia; FoxP3; immunosuppression; regulatory T cells; responder T cells

Mesh:

Substances:

Year:  2014        PMID: 24354800      PMCID: PMC3992054          DOI: 10.1111/imm.12237

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  56 in total

Review 1.  Failure of immune homeostasis -- the consequences of under and over reactivity.

Authors:  B Crimeen-Irwin; K Scalzo; S Gloster; P L Mottram; M Plebanski
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2005-12

2.  A single step purification of a sialic acid binding lectin (AchatininH) from Achatina fulica snail.

Authors:  S Basu; M Sarkar; C Mandal
Journal:  Mol Cell Biochem       Date:  1986-08       Impact factor: 3.396

3.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

4.  Chemical-modification studies of a unique sialic acid-binding lectin from the snail Achatina fulica. Involvement of tryptophan and histidine residues in biological activity.

Authors:  S Basu; C Mandal; A K Allen
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

5.  Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

Authors:  Marc Beyer; Matthias Kochanek; Kamruz Darabi; Alexey Popov; Markus Jensen; Elmar Endl; Percy A Knolle; Roman K Thomas; Michael von Bergwelt-Baildon; Svenja Debey; Michael Hallek; Joachim L Schultze
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

6.  Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo.

Authors:  Mei-Ling Chen; Mikaël J Pittet; Leonid Gorelik; Richard A Flavell; Ralph Weissleder; Harald von Boehmer; Khashayarsha Khazaie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-27       Impact factor: 11.205

Review 7.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

8.  [Regulatory T cells in children with acute lymphoblastic leukaemia].

Authors:  Anna Stasiak-Barmuta; Włodzimierz Łuczyński; Elzbieta Iłendo; Maryna Krawczuk-Rybak; Marcin Szymański
Journal:  Med Wieku Rozwoj       Date:  2009 Jan-Mar

9.  CD4+CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection.

Authors:  Emeka B Okeke; Ifeoma Okwor; Zhirong Mou; Ping Jia; Jude E Uzonna
Journal:  Shock       Date:  2013-07       Impact factor: 3.454

10.  Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.

Authors:  Daniel Rodriguez-Pinto; Adriana Navas; Víctor Manuel Blanco; Lady Ramírez; Daniel Garcerant; Adriana Cruz; Noah Craft; Nancy Gore Saravia
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24
View more
  13 in total

1.  Evaluation of the toxicity of iron-ion irradiation in murine bone marrow dendritic cells via increasing the expression of indoleamine 2,3-dioxygenase 1.

Authors:  Yi Xie; Jun-Fang Yan; Jing-Yi Ma; Hong-Yan Li; Yan-Cheng Ye; Yan-Shan Zhang; Hong Zhang
Journal:  Toxicol Res (Camb)       Date:  2017-09-25       Impact factor: 3.524

2.  The role of FOXP3 rs3761548 and rs2294021 polymorphisms in pediatrics acute lymphoblastic leukemia: association with risk and response to therapy.

Authors:  Zahra Ghasemi; Kurosh Kalantar; Zahra Amirghofran
Journal:  Mol Biol Rep       Date:  2021-01-30       Impact factor: 2.316

3.  End-stage renal disease, dialysis, kidney transplantation and their impact on CD4+ T-cell differentiation.

Authors:  Matthias Schaier; Angele Leick; Lorenz Uhlmann; Florian Kälble; Christian Morath; Volker Eckstein; Anthony Ho; Carsten Mueller-Tidow; Stefan Meuer; Karsten Mahnke; Claudia Sommerer; Martin Zeier; Andrea Steinborn
Journal:  Immunology       Date:  2018-05-25       Impact factor: 7.397

4.  Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer.

Authors:  Jie-Yao Li; Xiu-Fang Duan; Li-Ping Wang; Yu-Jie Xu; Lan Huang; Teng-Fei Zhang; Jin-Yan Liu; Feng Li; Zhen Zhang; Dong-Li Yue; Fei Wang; Bin Zhang; Yi Zhang
Journal:  J Immunol Res       Date:  2014-04-28       Impact factor: 4.818

Review 5.  Progress in Treatment of Viral Infections in Children with Acute Lymphoblastic Leukemia.

Authors:  Maria Moschovi; Maria Adamaki; Spiros A Vlahopoulos
Journal:  Oncol Rev       Date:  2016-06-30

Review 6.  Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies.

Authors:  Giovanni D'Arena; Candida Vitale; Marta Coscia; Agostino Festa; Nicola Matteo Dario Di Minno; Vincenzo De Feo; Michele Caraglia; Gioacchino Calapai; Luca Laurenti; Pellegrino Musto; Giovanni Di Minno; Daniela Fenoglio
Journal:  J Immunol Res       Date:  2017-12-21       Impact factor: 4.818

Review 7.  Toward Therapeutic Targeting of Bone Marrow Leukemic Niche Protective Signals in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Marjorie C Delahaye; Kaoutar-Insaf Salem; Jeoffrey Pelletier; Michel Aurrand-Lions; Stéphane J C Mancini
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

8.  Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.

Authors:  Asmaa M Zahran; Azza Shibl; Amal Rayan; Mohamed Alaa Eldeen Hassan Mohamed; Amira M M Osman; Khaled Saad; Khaled Hashim Mahmoud; Aliaa M A Ghandour; Khalid I Elsayh; Omnia El-Badawy
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  Porphyrin-Gold Nanomaterial for Efficient Drug Delivery to Cancerous Cells.

Authors:  Kaushik Bera; Samarpan Maiti; Mritunjoy Maity; Chitra Mandal; Nakul C Maiti
Journal:  ACS Omega       Date:  2018-04-26

10.  Imbalance of Chemokines and Cytokines in the Bone Marrow Microenvironment of Children with B-Cell Acute Lymphoblastic Leukemia.

Authors:  Fábio Magalhães-Gama; Marlon Wendell Athaydes Kerr; Nilberto Dias de Araújo; Hiochelson Najibe Santos Ibiapina; Juliana Costa Ferreira Neves; Fabíola Silva Alves Hanna; Lilyane de Amorim Xabregas; Maria Perpétuo Socorro Sampaio Carvalho; Eliana Brasil Alves; Andréa Monteiro Tarragô; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Adriana Malheiro; Allyson Guimarães da Costa
Journal:  J Oncol       Date:  2021-07-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.